Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment.
about
Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesModulation of h(2)s metabolism by statins: a new aspect of cardiovascular pharmacologyNovel recessive mutations in COQ4 cause severe infantile cardiomyopathy and encephalopathy associated with CoQ10 deficiency.Statins, Muscle Disease and Mitochondria.The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study.Drug-Induced Mitochondrial Toxicity.
P2860
Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Decreased ubiquinone availabil ...... ociated with statin treatment.
@en
Decreased ubiquinone availabil ...... ociated with statin treatment.
@nl
type
label
Decreased ubiquinone availabil ...... ociated with statin treatment.
@en
Decreased ubiquinone availabil ...... ociated with statin treatment.
@nl
prefLabel
Decreased ubiquinone availabil ...... ociated with statin treatment.
@en
Decreased ubiquinone availabil ...... ociated with statin treatment.
@nl
P2093
P2860
P1476
Decreased ubiquinone availabil ...... ociated with statin treatment.
@en
P2093
Andrew J Duncan
Iain P Hargreaves
John M Land
Maxwell S Damian
Simon J R Heales
P2860
P356
10.1080/15376510802305047
P577
2009-01-01T00:00:00Z